119 related articles for article (PubMed ID: 11264596)
21. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
Boussiotis VA; Freeman GJ; Gribben JG; Daley J; Gray G; Nadler LM
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11059-63. PubMed ID: 7504293
[TBL] [Abstract][Full Text] [Related]
22. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
[TBL] [Abstract][Full Text] [Related]
23. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
24. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
[TBL] [Abstract][Full Text] [Related]
25. A theoretical framework for quantitative analysis of the molecular basis of costimulation.
Jansson A; Barnes E; Klenerman P; Harlén M; Sørensen P; Davis SJ; Nilsson P
J Immunol; 2005 Aug; 175(3):1575-85. PubMed ID: 16034096
[TBL] [Abstract][Full Text] [Related]
26. CTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley PS; Brady W; Urnes M; Grosmaire LS; Damle NK; Ledbetter JA
J Exp Med; 1991 Sep; 174(3):561-9. PubMed ID: 1714933
[TBL] [Abstract][Full Text] [Related]
27. Expression of the costimulatory molecule BB-1 and its receptors in patients with scleroderma-polymyositis overlap syndrome.
Murata KY; Sugie K; Takamure M; Ueno S
J Neurol Sci; 2002 Dec; 205(1):65-70. PubMed ID: 12409186
[TBL] [Abstract][Full Text] [Related]
28. Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors.
Haffar OK; Smithgall MD; Bradshaw J; Brady B; Damle NK; Linsley PS
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11094-8. PubMed ID: 7504294
[TBL] [Abstract][Full Text] [Related]
29. Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.
Steiner K; Waase I; Rau T; Dietrich M; Fleischer B; Bröker BM
Clin Exp Immunol; 1999 Mar; 115(3):451-7. PubMed ID: 10193417
[TBL] [Abstract][Full Text] [Related]
30. Revealing the atomistic details behind the binding of B7-1 to CD28 and CTLA-4: A comprehensive protein-protein modelling study.
Ganesan A; Moon TC; Barakat KH
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2764-2778. PubMed ID: 30251665
[TBL] [Abstract][Full Text] [Related]
31. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
32. Suppression of experimental autoimmune encephalomyelitis using peptide mimics of CD28.
Srinivasan M; Gienapp IE; Stuckman SS; Rogers CJ; Jewell SD; Kaumaya PT; Whitacre CC
J Immunol; 2002 Aug; 169(4):2180-8. PubMed ID: 12165548
[TBL] [Abstract][Full Text] [Related]
33. The CD28-B7 costimulatory pathway and its role in autoimmune disease.
Daikh D; Wofsy D; Imboden JB
J Leukoc Biol; 1997 Aug; 62(2):156-62. PubMed ID: 9261329
[TBL] [Abstract][Full Text] [Related]
34. CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells.
Huang JH; Tykocinski ML
Int Immunol; 2001 Apr; 13(4):529-39. PubMed ID: 11282992
[TBL] [Abstract][Full Text] [Related]
35. Blockade of CD28/B7 interaction suppresses allergic eosinophilic inflammation in mice.
Kasai M; Kumano K; Kurasawa K; Nakao A; Saito Y; Iwamoto I
Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():14-9. PubMed ID: 9758890
[TBL] [Abstract][Full Text] [Related]
36. Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2.
Wagner DH; Hagman J; Linsley PS; Hodsdon W; Freed JH; Newell MK
J Exp Med; 1996 Nov; 184(5):1631-8. PubMed ID: 8920853
[TBL] [Abstract][Full Text] [Related]
37. Cloning of avian and bovine CD80 using chimeric fusion proteins to detect expression.
Parsons KR; O'Regan M; Young JR; Howard CJ
Biochem Soc Trans; 1997 May; 25(2):203S. PubMed ID: 9191247
[No Abstract] [Full Text] [Related]
38. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7.
Vaughan AN; Malde P; Rogers NJ; Jackson IM; Lechler RI; Dorling A
J Immunol; 2000 Sep; 165(6):3175-81. PubMed ID: 10975832
[TBL] [Abstract][Full Text] [Related]
39. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.
García-Cózar FJ; Molina IJ; Cuadrado MJ; Marubayashi M; Peña J; Santamaría M
Clin Exp Immunol; 1996 Apr; 104(1):72-9. PubMed ID: 8603537
[TBL] [Abstract][Full Text] [Related]
40. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel MF; Allison JP
J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]